Astrazeneca AZN
NYSE AZN
$159.18 +0.57 (+0.36%)
At close: Oct 9, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Income towards Parent Company (2009 - 2026)

Updated

Astrazeneca (AZN) recorded Income towards Parent Company of $2.89 billion in Q2 2026, down 18.6% from $3.56 billion a year earlier and down 6.1% from the prior quarter.

Analysis

Astrazeneca (AZN) Income towards Parent Company (2009 - 2026) Analysis & Trends

On a TTM basis, Astrazeneca's Income towards Parent Company came in at $10.87 billion as of Jun 30, 2026, up 2.3% year-over-year; for FY2025, it was $12.92 billion, up 107.2% from FY2024.

  • Annual Income towards Parent Company has a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
  • Across earlier years, Income towards Parent Company came in at $6.24 billion in FY2024 (-6.8%), $6.69 billion in FY2023 (+177.2%), $2.41 billion in FY2022 and $112 million in FY2021 (-97.7%).
  • Quarterly Income towards Parent Company has ranged from -$1.98 billion in Q3 2021 to $3.56 billion in Q2 2025 over the past five years.
  • On a year-over-year basis, Income towards Parent Company rose in five of the last eight quarters, with growth averaging 35.6%.
  • Peak year-over-year performance for Income towards Parent Company in the last five years was growth of 438.5% in Q1 2023, against a decline of 74.1% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.08 billion (Q1 2026), $2.33 billion (Q4 2025) and $2.58 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.51 Bn
Mar 31, 2026 3.08 Bn
Dec 31, 2025 2.33 Bn
Sep 30, 2025 2.53 Bn
Jun 30, 2025 2.45 Bn
Mar 31, 2025 2.92 Bn
Dec 31, 2024 1.50 Bn
Sep 30, 2024 1.43 Bn
Jun 30, 2024 1.93 Bn
Mar 31, 2024 2.18 Bn
Dec 31, 2023 960.00 Mn
Sep 30, 2023 1.37 Bn
Jun 30, 2023 1.82 Bn
Mar 31, 2023 1.80 Bn
Dec 31, 2022 901.00 Mn
Sep 30, 2022 1.64 Bn
Jun 30, 2022 360.00 Mn
Mar 31, 2022 386.00 Mn
Dec 31, 2021 -347.00 Mn
Sep 30, 2021 -1.65 Bn
API Access

Astrazeneca Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AZN&period=max&api_key=YOUR_API_KEY